Institutional investors purchased a net $794.3 thousand shares of MDCO during the quarter ended December 2015 and now own 120.04% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SARISSA CAPITAL MANAGEMENT LP Bought 185.0 Thousand shares of Medicines Co
FOX RUN MANAGEMENT LLC Bought 13.6 Thousand shares of Medicines Co
CANDRIAM LUXEMBOURG SA Bought 11.7 Thousand shares of Medicines Co